• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过多分类多目标放射基因组学模型实现透明细胞肾细胞癌中可靠的基因突变预测。

Reliable gene mutation prediction in clear cell renal cell carcinoma through multi-classifier multi-objective radiogenomics model.

机构信息

School of Electronic and Information Engineering, Xi'an Jiaotong University, Xi'an, Shaanxi 710049, People's Repubic of China.

出版信息

Phys Med Biol. 2018 Oct 24;63(21):215008. doi: 10.1088/1361-6560/aae5cd.

DOI:10.1088/1361-6560/aae5cd
PMID:30277889
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6240911/
Abstract

Genetic studies have identified associations between gene mutations and clear cell renal cell carcinoma (ccRCC). Since the complete gene mutational landscape cannot be characterized through biopsy and sequencing assays for each patient, non-invasive tools are needed to determine the mutation status for tumors. Radiogenomics may be an attractive alternative tool to identify disease genomics by analyzing amounts of features extracted from medical images. Most current radiogenomics predictive models are built based on a single classifier and trained through a single objective. However, since many classifiers are available, selecting an optimal model is challenging. On the other hand, a single objective may not be a good measure to guide model training. We proposed a new multi-classifier multi-objective (MCMO) radiogenomics predictive model. To obtain more reliable prediction results, similarity-based sensitivity and specificity were defined and considered as the two objective functions simultaneously during training. To take advantage of different classifiers, the evidential reasoning (ER) approach was used for fusing the output of each classifier. Additionally, a new similarity-based multi-objective optimization algorithm (SMO) was developed for training the MCMO to predict ccRCC related gene mutations (VHL, PBRM1 and BAP1) using quantitative CT features. Using the proposed MCMO model, we achieved a predictive area under the receiver operating characteristic curve (AUC) over 0.85 for VHL, PBRM1 and BAP1 genes with balanced sensitivity and specificity. Furthermore, MCMO outperformed all the individual classifiers, and yielded more reliable results than other optimization algorithms and commonly used fusion strategies.

摘要

遗传研究已经确定了基因突变与透明细胞肾细胞癌(ccRCC)之间的关联。由于无法通过对每个患者进行活检和测序来确定完整的基因突变全景,因此需要非侵入性工具来确定肿瘤的突变状态。放射基因组学可以通过分析从医学图像中提取的特征量来识别疾病基因组学,这可能是一种很有吸引力的替代工具。目前大多数放射基因组学预测模型都是基于单个分类器构建的,并通过单一目标进行训练。然而,由于有许多分类器可供选择,因此选择最佳模型是具有挑战性的。另一方面,单一目标可能不是指导模型训练的好方法。我们提出了一种新的多分类器多目标(MCMO)放射基因组学预测模型。为了获得更可靠的预测结果,定义了基于相似度的灵敏度和特异性,并在训练过程中同时将其视为两个目标函数。为了利用不同的分类器,使用证据推理(ER)方法融合每个分类器的输出。此外,还开发了一种新的基于相似度的多目标优化算法(SMO),用于使用定量 CT 特征训练 MCMO 来预测 ccRCC 相关基因突变(VHL、PBRM1 和 BAP1)。使用所提出的 MCMO 模型,我们在 VHL、PBRM1 和 BAP1 基因上实现了超过 0.85 的接收器操作特征曲线下的预测面积(AUC),具有平衡的灵敏度和特异性。此外,MCMO 优于所有单个分类器,并产生了比其他优化算法和常用融合策略更可靠的结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cce/6240911/b1bfceef3ad2/nihms-1511079-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cce/6240911/33d184e24266/nihms-1511079-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cce/6240911/7bd19cac3332/nihms-1511079-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cce/6240911/564561bbb112/nihms-1511079-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cce/6240911/e48b11918fbf/nihms-1511079-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cce/6240911/9d935101d37a/nihms-1511079-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cce/6240911/9ab21e08ab2d/nihms-1511079-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cce/6240911/5647857e070e/nihms-1511079-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cce/6240911/61fd38521466/nihms-1511079-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cce/6240911/b1bfceef3ad2/nihms-1511079-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cce/6240911/33d184e24266/nihms-1511079-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cce/6240911/7bd19cac3332/nihms-1511079-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cce/6240911/564561bbb112/nihms-1511079-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cce/6240911/e48b11918fbf/nihms-1511079-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cce/6240911/9d935101d37a/nihms-1511079-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cce/6240911/9ab21e08ab2d/nihms-1511079-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cce/6240911/5647857e070e/nihms-1511079-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cce/6240911/61fd38521466/nihms-1511079-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cce/6240911/b1bfceef3ad2/nihms-1511079-f0009.jpg

相似文献

1
Reliable gene mutation prediction in clear cell renal cell carcinoma through multi-classifier multi-objective radiogenomics model.通过多分类多目标放射基因组学模型实现透明细胞肾细胞癌中可靠的基因突变预测。
Phys Med Biol. 2018 Oct 24;63(21):215008. doi: 10.1088/1361-6560/aae5cd.
2
Radiogenomics in Clear Cell Renal Cell Carcinoma: Machine Learning-Based High-Dimensional Quantitative CT Texture Analysis in Predicting PBRM1 Mutation Status.透明细胞肾细胞癌的放射组基因组学:基于机器学习的高维定量 CT 纹理分析在预测 PBRM1 突变状态中的应用。
AJR Am J Roentgenol. 2019 Mar;212(3):W55-W63. doi: 10.2214/AJR.18.20443. Epub 2019 Jan 2.
3
A Reliable Multi-classifier Multi-objective Model for Predicting Recurrence in Triple Negative Breast Cancer.一种用于预测三阴性乳腺癌复发的可靠多分类器多目标模型。
Annu Int Conf IEEE Eng Med Biol Soc. 2019 Jul;2019:2182-2185. doi: 10.1109/EMBC.2019.8857030.
4
Integrative radiogenomics analysis for predicting molecular features and survival in clear cell renal cell carcinoma.整合放射基因组学分析预测透明细胞肾细胞癌的分子特征和生存。
Aging (Albany NY). 2021 Mar 26;13(7):9960-9975. doi: 10.18632/aging.202752.
5
Machine learning-based unenhanced CT texture analysis for predicting BAP1 mutation status of clear cell renal cell carcinomas.基于机器学习的非增强CT纹理分析预测透明细胞肾细胞癌的BAP1突变状态
Acta Radiol. 2020 Jun;61(6):856-864. doi: 10.1177/0284185119881742. Epub 2019 Oct 21.
6
Radiogenomics of clear cell renal cell carcinoma: preliminary findings of The Cancer Genome Atlas-Renal Cell Carcinoma (TCGA-RCC) Imaging Research Group.透明细胞肾细胞癌的放射基因组学:癌症基因组图谱 - 肾细胞癌(TCGA - RCC)影像研究组的初步发现
Abdom Imaging. 2015 Aug;40(6):1684-92. doi: 10.1007/s00261-015-0386-z.
7
Radiogenomic analysis based on lipid metabolism-related subset for non-invasive prediction for prognosis of renal clear cell carcinoma.基于脂质代谢相关亚组的放射基因组分析用于无创预测肾透明细胞癌的预后。
Eur J Radiol. 2024 Jun;175:111433. doi: 10.1016/j.ejrad.2024.111433. Epub 2024 Mar 16.
8
Radiogenomics in renal cell carcinoma.肾癌的放射基因组学。
Abdom Radiol (NY). 2019 Jun;44(6):1990-1998. doi: 10.1007/s00261-018-1624-y.
9
Deep feature classification of angiomyolipoma without visible fat and renal cell carcinoma in abdominal contrast-enhanced CT images with texture image patches and hand-crafted feature concatenation.利用纹理图像补丁和手工特征串联对腹部增强 CT 图像中无可见脂肪的血管平滑肌脂肪瘤和肾细胞癌进行深度特征分类。
Med Phys. 2018 Apr;45(4):1550-1561. doi: 10.1002/mp.12828. Epub 2018 Mar 25.
10
Differentiation of fat-poor angiomyolipoma from clear cell renal cell carcinoma in contrast-enhanced MDCT images using quantitative feature classification.基于定量特征分类的 MDCT 增强图像鉴别乏脂性血管平滑肌脂肪瘤与透明细胞肾细胞癌
Med Phys. 2017 Jul;44(7):3604-3614. doi: 10.1002/mp.12258. Epub 2017 Jun 9.

引用本文的文献

1
Failure to Suppress Progression in Clear Cell Renal Cell Carcinoma Associated with NCOA7 Low Expression Revealed Through Radiogenomic Analysis.通过放射基因组分析揭示NCOA7低表达与透明细胞肾细胞癌进展抑制失败相关
Genes (Basel). 2025 Mar 28;16(4):386. doi: 10.3390/genes16040386.
2
From Images to Genes: Radiogenomics Based on Artificial Intelligence to Achieve Non-Invasive Precision Medicine in Cancer Patients.从图像到基因:基于人工智能的放射基因组学助力癌症患者实现无创精准医疗
Adv Sci (Weinh). 2025 Jan;12(2):e2408069. doi: 10.1002/advs.202408069. Epub 2024 Nov 13.
3
Radiology and multi-scale data integration for precision oncology.

本文引用的文献

1
Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.肾癌,2017 年第 2 版,NCCN 肿瘤学临床实践指南。
J Natl Compr Canc Netw. 2017 Jun;15(6):804-834. doi: 10.6004/jnccn.2017.0100.
2
Multi-objective radiomics model for predicting distant failure in lung SBRT.用于预测肺立体定向体部放疗远处失败的多目标放射组学模型
Phys Med Biol. 2017 Jun 7;62(11):4460-4478. doi: 10.1088/1361-6560/aa6ae5. Epub 2017 May 8.
3
Predictive radiogenomics modeling of EGFR mutation status in lung cancer.预测放射基因组学模型在肺癌中 EGFR 突变状态的应用。
用于精准肿瘤学的放射学与多尺度数据整合
NPJ Precis Oncol. 2024 Jul 26;8(1):158. doi: 10.1038/s41698-024-00656-0.
4
Advancements in Radiogenomics for Clear Cell Renal Cell Carcinoma: Understanding the Impact of BAP1 Mutation.透明细胞肾细胞癌放射基因组学的进展:了解BAP1突变的影响
J Clin Med. 2024 Jul 6;13(13):3960. doi: 10.3390/jcm13133960.
5
Multimodal data integration using machine learning to predict the risk of clear cell renal cancer metastasis: a retrospective multicentre study.基于机器学习的多模态数据整合预测透明细胞肾细胞癌转移风险:一项回顾性多中心研究。
Abdom Radiol (NY). 2024 Jul;49(7):2311-2324. doi: 10.1007/s00261-024-04418-1. Epub 2024 Jun 15.
6
The influence of manual segmentation strategies and different phases selection on machine learning-based computed tomography in renal tumors: a systematic review and meta-analysis.基于机器学习的计算机断层扫描在肾肿瘤中的手动分割策略和不同相位选择的影响:系统评价和荟萃分析。
Radiol Med. 2024 Jul;129(7):1025-1037. doi: 10.1007/s11547-024-01825-8. Epub 2024 May 13.
7
Radiogenomics and Texture Analysis to Detect von Hippel-Lindau (VHL) Mutation in Clear Cell Renal Cell Carcinoma.利用放射基因组学和纹理分析检测透明细胞肾细胞癌中的冯·希佩尔-林道(VHL)突变
Curr Issues Mol Biol. 2024 Apr 8;46(4):3236-3250. doi: 10.3390/cimb46040203.
8
Genetic and Epigenetic Characteristics in Isolated Pancreatic Metastases of Clear-Cell Renal Cell Carcinoma.孤立性胰腺透明细胞肾细胞癌转移的遗传和表观遗传特征。
Int J Mol Sci. 2023 Nov 14;24(22):16292. doi: 10.3390/ijms242216292.
9
Interpretability of radiomics models is improved when using feature group selection strategies for predicting molecular and clinical targets in clear-cell renal cell carcinoma: insights from the TRACERx Renal study.当使用特征组选择策略来预测透明细胞肾细胞癌的分子和临床靶标时,放射组学模型的可解释性得到提高:来自 TRACERx Renal 研究的见解。
Cancer Imaging. 2023 Aug 14;23(1):76. doi: 10.1186/s40644-023-00594-3.
10
Artificial intelligence and radiomics in evaluation of kidney lesions: a comprehensive literature review.人工智能与影像组学在肾脏病变评估中的应用:一项综合文献综述
Ther Adv Urol. 2023 Apr 17;15:17562872231164803. doi: 10.1177/17562872231164803. eCollection 2023 Jan-Dec.
Sci Rep. 2017 Jan 31;7:41674. doi: 10.1038/srep41674.
4
Cancer Statistics, 2017.《2017 年癌症统计》
CA Cancer J Clin. 2017 Jan;67(1):7-30. doi: 10.3322/caac.21387. Epub 2017 Jan 5.
5
Unravelling tumour heterogeneity using next-generation imaging: radiomics, radiogenomics, and habitat imaging.利用下一代成像技术解析肿瘤异质性:放射组学、放射基因组学和栖息地成像
Clin Radiol. 2017 Jan;72(1):3-10. doi: 10.1016/j.crad.2016.09.013. Epub 2016 Oct 11.
6
Using machine learning to predict radiation pneumonitis in patients with stage I non-small cell lung cancer treated with stereotactic body radiation therapy.利用机器学习预测接受立体定向体部放射治疗的I期非小细胞肺癌患者的放射性肺炎。
Phys Med Biol. 2016 Aug 21;61(16):6105-20. doi: 10.1088/0031-9155/61/16/6105. Epub 2016 Jul 27.
7
Oncologic Surveillance After Surgical Resection for Renal Cell Carcinoma: A Novel Risk-Based Approach.肾细胞癌切除术后的肿瘤监测:一种新的基于风险的方法。
J Clin Oncol. 2015 Dec 10;33(35):4151-7. doi: 10.1200/JCO.2015.61.8009. Epub 2015 Sep 8.
8
Measuring Computed Tomography Scanner Variability of Radiomics Features.测量计算机断层扫描扫描仪的影像组学特征变异性。
Invest Radiol. 2015 Nov;50(11):757-65. doi: 10.1097/RLI.0000000000000180.
9
Radiogenomics of clear cell renal cell carcinoma: preliminary findings of The Cancer Genome Atlas-Renal Cell Carcinoma (TCGA-RCC) Imaging Research Group.透明细胞肾细胞癌的放射基因组学:癌症基因组图谱 - 肾细胞癌(TCGA - RCC)影像研究组的初步发现
Abdom Imaging. 2015 Aug;40(6):1684-92. doi: 10.1007/s00261-015-0386-z.
10
Biological and therapeutic impact of intratumor heterogeneity in cancer evolution.肿瘤内异质性在癌症进化中的生物学和治疗影响。
Cancer Cell. 2015 Jan 12;27(1):15-26. doi: 10.1016/j.ccell.2014.12.001.